Erkki Ruoslahti (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Erkki Ruoslahti" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

18^th place

17^th place

2sbpdiscovery.org

low place

low place

2web.archive.org

1^st place

1^st place

22^nd place

19^th place

1semanticscholar.org

11^th place

8^th place

5^th place

5^th place

1sanfordburnham.org

low place

low place

1sciencemag.org

857^th place

3,832^nd place

1laskerfoundation.org

low place

low place

low place

low place

3,325^th place

2,396^th place

aacr.org

AACR Academy Fellows: Erkki Ruoslahti.

doi.org

Ruoslahti, E; Pierschbacher, MD (1987). "New perspectives in cell adhesion: RGD and integrins". Science. 238 (4826): 491–497. Bibcode:1987Sci...238..491R. doi:10.1126/science.2821619. PMID 2821619.
Pierschbacher, MD; Ruoslahti, E (1984). "Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule". Nature. 309 (5963): 30–33. Bibcode:1984Natur.309...30P. doi:10.1038/309030a0. PMID 6325925. S2CID 4371931.
Dedhar, S; Ruoslahti, E; Pierschbacher, MD (1987). "A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence". J Cell Biol. 104 (3): 585–593. doi:10.1083/jcb.104.3.585. PMC 2114550. PMID 3469204.
Ley, K; Rivera-Nieves, J; Sandborn, WJ; Shattil, S (2016). "Integrin-based therapeutics: biological basis, clinical use and new drugs". Nat Rev Drug Discov. 15 (3): 173–183. doi:10.1038/nrd.2015.10. PMC 4890615. PMID 26822833.
Ruoslahti, E. (2004). "Vascular zip codes in angiogenesis and metastasis". Biochem Soc Trans. 32 (3): 397–402. doi:10.1042/bst0320397. ISSN 0300-5127. PMID 15157146.
Teesalu, T.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E. (2009). "C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration". Proc Natl Acad Sci USA. 106 (38): 16157–16162. Bibcode:2009PNAS..10616157T. doi:10.1073/pnas.0908201106. PMC 2752543. PMID 19805273.
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Girard, O. M.; Hanahan, D.; Mattrey, R. F.; Ruoslahti, E. (2009). "Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors". Cancer Cell. 16 (6): 510–520. doi:10.1016/j.ccr.2009.10.013. PMC 2791543. PMID 19962669.
Pang, HB; Braun, GB; Friman, T; Aza-Blanc, P; Ruidiaz, ME; Sugahara, KN; Teesalu, T; Ruoslahti, E (2014). "An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability". Nat Commun. 5: ncomms5904. Bibcode:2014NatCo...5.4904P. doi:10.1038/ncomms5904. PMC 4185402. PMID 25277522.
Pang, HB; Braun, GB; Ruoslahti, E (2015). "Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides". Sci Adv. 1 (10): e1500821. Bibcode:2015SciA....1E0821P. doi:10.1126/sciadv.1500821. PMC 4640594. PMID 26601141.
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. (2010). "Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs". Science. 328 (5981): 1031–1035. Bibcode:2010Sci...328.1031S. doi:10.1126/science.1183057. PMC 2881692. PMID 20378772.
Agemy, L; Kotamraju, VR; Friedmann-Morvinski, D; Sharma, S; Sugahara, KN; Ruoslahti, E (2013). "Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32". Mol Ther. 21 (12): 2195–2204. doi:10.1038/mt.2013.191. PMC 3863797. PMID 23959073.
Sharma, S; Kotamraju, VR; Mölder, T; Tobi, A; Teesalu, T; Ruoslahti, E (2017). "Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth". Nano Lett. 17 (3): 1356–1364. Bibcode:2017NanoL..17.1356S. doi:10.1021/acs.nanolett.6b03815. PMC 5819594. PMID 28178415.
King, A; Ndifon, C; Lui, S; Widdows, K; Kotamraju, VR; Agemy, L; Teesalu, T; Glazier, JD; Cellesi, F; Tirelli, N; Aplin, JD; Ruoslahti, E; Harris, LK (2016). "Tumor-homing peptides as tools for targeted delivery of payloads to the placenta". Sci Adv. 2 (5): e1600349. Bibcode:2016SciA....2E0349K. doi:10.1126/sciadv.1600349. PMC 4928982. PMID 27386551.
Toba, M; Alzoubi, A; O’Neill, K; Abe, ohtaro; Urakami, T; Komatsu, M; Alvarez, D; Järvinen, TAH; Mann, D (2014). "A Novel Vascular Homing Peptide Strategy to Selectively Enhance Pulmonary Drug Efficacy in Pulmonary Arterial Hypertension". Am J Pathol. 184 (2): 369–375. doi:10.1016/j.ajpath.2013.10.008. PMC 3906494. PMID 24401613.
She, ZG; Hamzah, J; Kotamraju, VR; Pang, HB; Jansen, S; Ruoslahti, E (2016). "Plaque-penetrating peptide inhibits development of hypoxic atherosclerotic plaque". J Control Release. 238: 212–220. doi:10.1016/j.jconrel.2016.07.020. PMID 27423327.
Mann, AP; Scodeller, P; Hussain, S; Joo, J; Kwon, E; Braun, GB; Mölder, T; She, Z; Kotamraju, VR; Ranscht, B; Krajewski, S; Teesalu, T; Bhatia, S; Sailor, MJ; Ruoslahti, E (2016). "A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries". Nat Commun. 7: 11980. Bibcode:2016NatCo...711980M. doi:10.1038/ncomms11980. PMC 4931241. PMID 27351915.

harvard.edu

ui.adsabs.harvard.edu

Ruoslahti, E; Pierschbacher, MD (1987). "New perspectives in cell adhesion: RGD and integrins". Science. 238 (4826): 491–497. Bibcode:1987Sci...238..491R. doi:10.1126/science.2821619. PMID 2821619.
Pierschbacher, MD; Ruoslahti, E (1984). "Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule". Nature. 309 (5963): 30–33. Bibcode:1984Natur.309...30P. doi:10.1038/309030a0. PMID 6325925. S2CID 4371931.
Teesalu, T.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E. (2009). "C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration". Proc Natl Acad Sci USA. 106 (38): 16157–16162. Bibcode:2009PNAS..10616157T. doi:10.1073/pnas.0908201106. PMC 2752543. PMID 19805273.
Pang, HB; Braun, GB; Friman, T; Aza-Blanc, P; Ruidiaz, ME; Sugahara, KN; Teesalu, T; Ruoslahti, E (2014). "An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability". Nat Commun. 5: ncomms5904. Bibcode:2014NatCo...5.4904P. doi:10.1038/ncomms5904. PMC 4185402. PMID 25277522.
Pang, HB; Braun, GB; Ruoslahti, E (2015). "Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides". Sci Adv. 1 (10): e1500821. Bibcode:2015SciA....1E0821P. doi:10.1126/sciadv.1500821. PMC 4640594. PMID 26601141.
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. (2010). "Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs". Science. 328 (5981): 1031–1035. Bibcode:2010Sci...328.1031S. doi:10.1126/science.1183057. PMC 2881692. PMID 20378772.
Sharma, S; Kotamraju, VR; Mölder, T; Tobi, A; Teesalu, T; Ruoslahti, E (2017). "Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth". Nano Lett. 17 (3): 1356–1364. Bibcode:2017NanoL..17.1356S. doi:10.1021/acs.nanolett.6b03815. PMC 5819594. PMID 28178415.
King, A; Ndifon, C; Lui, S; Widdows, K; Kotamraju, VR; Agemy, L; Teesalu, T; Glazier, JD; Cellesi, F; Tirelli, N; Aplin, JD; Ruoslahti, E; Harris, LK (2016). "Tumor-homing peptides as tools for targeted delivery of payloads to the placenta". Sci Adv. 2 (5): e1600349. Bibcode:2016SciA....2E0349K. doi:10.1126/sciadv.1600349. PMC 4928982. PMID 27386551.
Mann, AP; Scodeller, P; Hussain, S; Joo, J; Kwon, E; Braun, GB; Mölder, T; She, Z; Kotamraju, VR; Ranscht, B; Krajewski, S; Teesalu, T; Bhatia, S; Sailor, MJ; Ruoslahti, E (2016). "A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries". Nat Commun. 7: 11980. Bibcode:2016NatCo...711980M. doi:10.1038/ncomms11980. PMC 4931241. PMID 27351915.

laskerfoundation.org

Albert Lasker Award for Basic Medical Research.

latimes.com

Closing In on Cancer : In Search of a Cure, a La Jolla Research Center Reaches Into the Outer Limits Los Angeles Times

nasonline.org

"Erkki Ruoslahti". United States National Academy of Sciences. Retrieved 14 March 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ruoslahti, E; Pierschbacher, MD (1987). "New perspectives in cell adhesion: RGD and integrins". Science. 238 (4826): 491–497. Bibcode:1987Sci...238..491R. doi:10.1126/science.2821619. PMID 2821619.
Pierschbacher, MD; Ruoslahti, E (1984). "Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule". Nature. 309 (5963): 30–33. Bibcode:1984Natur.309...30P. doi:10.1038/309030a0. PMID 6325925. S2CID 4371931.
Dedhar, S; Ruoslahti, E; Pierschbacher, MD (1987). "A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence". J Cell Biol. 104 (3): 585–593. doi:10.1083/jcb.104.3.585. PMC 2114550. PMID 3469204.
Ley, K; Rivera-Nieves, J; Sandborn, WJ; Shattil, S (2016). "Integrin-based therapeutics: biological basis, clinical use and new drugs". Nat Rev Drug Discov. 15 (3): 173–183. doi:10.1038/nrd.2015.10. PMC 4890615. PMID 26822833.
Ruoslahti, E. (2004). "Vascular zip codes in angiogenesis and metastasis". Biochem Soc Trans. 32 (3): 397–402. doi:10.1042/bst0320397. ISSN 0300-5127. PMID 15157146.
Teesalu, T.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E. (2009). "C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration". Proc Natl Acad Sci USA. 106 (38): 16157–16162. Bibcode:2009PNAS..10616157T. doi:10.1073/pnas.0908201106. PMC 2752543. PMID 19805273.
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Girard, O. M.; Hanahan, D.; Mattrey, R. F.; Ruoslahti, E. (2009). "Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors". Cancer Cell. 16 (6): 510–520. doi:10.1016/j.ccr.2009.10.013. PMC 2791543. PMID 19962669.
Pang, HB; Braun, GB; Friman, T; Aza-Blanc, P; Ruidiaz, ME; Sugahara, KN; Teesalu, T; Ruoslahti, E (2014). "An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability". Nat Commun. 5: ncomms5904. Bibcode:2014NatCo...5.4904P. doi:10.1038/ncomms5904. PMC 4185402. PMID 25277522.
Pang, HB; Braun, GB; Ruoslahti, E (2015). "Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides". Sci Adv. 1 (10): e1500821. Bibcode:2015SciA....1E0821P. doi:10.1126/sciadv.1500821. PMC 4640594. PMID 26601141.
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. (2010). "Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs". Science. 328 (5981): 1031–1035. Bibcode:2010Sci...328.1031S. doi:10.1126/science.1183057. PMC 2881692. PMID 20378772.
Agemy, L; Kotamraju, VR; Friedmann-Morvinski, D; Sharma, S; Sugahara, KN; Ruoslahti, E (2013). "Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32". Mol Ther. 21 (12): 2195–2204. doi:10.1038/mt.2013.191. PMC 3863797. PMID 23959073.
Sharma, S; Kotamraju, VR; Mölder, T; Tobi, A; Teesalu, T; Ruoslahti, E (2017). "Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth". Nano Lett. 17 (3): 1356–1364. Bibcode:2017NanoL..17.1356S. doi:10.1021/acs.nanolett.6b03815. PMC 5819594. PMID 28178415.
King, A; Ndifon, C; Lui, S; Widdows, K; Kotamraju, VR; Agemy, L; Teesalu, T; Glazier, JD; Cellesi, F; Tirelli, N; Aplin, JD; Ruoslahti, E; Harris, LK (2016). "Tumor-homing peptides as tools for targeted delivery of payloads to the placenta". Sci Adv. 2 (5): e1600349. Bibcode:2016SciA....2E0349K. doi:10.1126/sciadv.1600349. PMC 4928982. PMID 27386551.
Toba, M; Alzoubi, A; O’Neill, K; Abe, ohtaro; Urakami, T; Komatsu, M; Alvarez, D; Järvinen, TAH; Mann, D (2014). "A Novel Vascular Homing Peptide Strategy to Selectively Enhance Pulmonary Drug Efficacy in Pulmonary Arterial Hypertension". Am J Pathol. 184 (2): 369–375. doi:10.1016/j.ajpath.2013.10.008. PMC 3906494. PMID 24401613.
She, ZG; Hamzah, J; Kotamraju, VR; Pang, HB; Jansen, S; Ruoslahti, E (2016). "Plaque-penetrating peptide inhibits development of hypoxic atherosclerotic plaque". J Control Release. 238: 212–220. doi:10.1016/j.jconrel.2016.07.020. PMID 27423327.
Mann, AP; Scodeller, P; Hussain, S; Joo, J; Kwon, E; Braun, GB; Mölder, T; She, Z; Kotamraju, VR; Ranscht, B; Krajewski, S; Teesalu, T; Bhatia, S; Sailor, MJ; Ruoslahti, E (2016). "A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries". Nat Commun. 7: 11980. Bibcode:2016NatCo...711980M. doi:10.1038/ncomms11980. PMC 4931241. PMID 27351915.

ncbi.nlm.nih.gov

Dedhar, S; Ruoslahti, E; Pierschbacher, MD (1987). "A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence". J Cell Biol. 104 (3): 585–593. doi:10.1083/jcb.104.3.585. PMC 2114550. PMID 3469204.
Ley, K; Rivera-Nieves, J; Sandborn, WJ; Shattil, S (2016). "Integrin-based therapeutics: biological basis, clinical use and new drugs". Nat Rev Drug Discov. 15 (3): 173–183. doi:10.1038/nrd.2015.10. PMC 4890615. PMID 26822833.
Teesalu, T.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E. (2009). "C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration". Proc Natl Acad Sci USA. 106 (38): 16157–16162. Bibcode:2009PNAS..10616157T. doi:10.1073/pnas.0908201106. PMC 2752543. PMID 19805273.
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Girard, O. M.; Hanahan, D.; Mattrey, R. F.; Ruoslahti, E. (2009). "Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors". Cancer Cell. 16 (6): 510–520. doi:10.1016/j.ccr.2009.10.013. PMC 2791543. PMID 19962669.
Pang, HB; Braun, GB; Friman, T; Aza-Blanc, P; Ruidiaz, ME; Sugahara, KN; Teesalu, T; Ruoslahti, E (2014). "An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability". Nat Commun. 5: ncomms5904. Bibcode:2014NatCo...5.4904P. doi:10.1038/ncomms5904. PMC 4185402. PMID 25277522.
Pang, HB; Braun, GB; Ruoslahti, E (2015). "Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides". Sci Adv. 1 (10): e1500821. Bibcode:2015SciA....1E0821P. doi:10.1126/sciadv.1500821. PMC 4640594. PMID 26601141.
Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. (2010). "Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs". Science. 328 (5981): 1031–1035. Bibcode:2010Sci...328.1031S. doi:10.1126/science.1183057. PMC 2881692. PMID 20378772.
Agemy, L; Kotamraju, VR; Friedmann-Morvinski, D; Sharma, S; Sugahara, KN; Ruoslahti, E (2013). "Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32". Mol Ther. 21 (12): 2195–2204. doi:10.1038/mt.2013.191. PMC 3863797. PMID 23959073.
Sharma, S; Kotamraju, VR; Mölder, T; Tobi, A; Teesalu, T; Ruoslahti, E (2017). "Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth". Nano Lett. 17 (3): 1356–1364. Bibcode:2017NanoL..17.1356S. doi:10.1021/acs.nanolett.6b03815. PMC 5819594. PMID 28178415.
King, A; Ndifon, C; Lui, S; Widdows, K; Kotamraju, VR; Agemy, L; Teesalu, T; Glazier, JD; Cellesi, F; Tirelli, N; Aplin, JD; Ruoslahti, E; Harris, LK (2016). "Tumor-homing peptides as tools for targeted delivery of payloads to the placenta". Sci Adv. 2 (5): e1600349. Bibcode:2016SciA....2E0349K. doi:10.1126/sciadv.1600349. PMC 4928982. PMID 27386551.
Toba, M; Alzoubi, A; O’Neill, K; Abe, ohtaro; Urakami, T; Komatsu, M; Alvarez, D; Järvinen, TAH; Mann, D (2014). "A Novel Vascular Homing Peptide Strategy to Selectively Enhance Pulmonary Drug Efficacy in Pulmonary Arterial Hypertension". Am J Pathol. 184 (2): 369–375. doi:10.1016/j.ajpath.2013.10.008. PMC 3906494. PMID 24401613.
Mann, AP; Scodeller, P; Hussain, S; Joo, J; Kwon, E; Braun, GB; Mölder, T; She, Z; Kotamraju, VR; Ranscht, B; Krajewski, S; Teesalu, T; Bhatia, S; Sailor, MJ; Ruoslahti, E (2016). "A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries". Nat Commun. 7: 11980. Bibcode:2016NatCo...711980M. doi:10.1038/ncomms11980. PMC 4931241. PMID 27351915.

sanfordburnham.org

"Cancer Drug Effectiveness Substantially Advanced". Archived from the original on May 7, 2010. Retrieved April 17, 2010.

sbpdiscovery.org

"Erkki Ruoslahti". Sanford Burnham Prebys Medical Discovery Institute. Retrieved October 30, 2017.
"Compound discovered at Sanford Burnham Prebys advances into Phase 1 trial for pancreatic cancer | SBP".

sciencemag.org

news.sciencemag.org

Couzin-Frankel, Jennifer (8 April 2010). "New Peptide Helps Cancer Drugs Break Into Tumors". ScienceNOW. Archived from the original on June 8, 2013. Retrieved March 14, 2013.

semanticscholar.org

api.semanticscholar.org

Pierschbacher, MD; Ruoslahti, E (1984). "Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule". Nature. 309 (5963): 30–33. Bibcode:1984Natur.309...30P. doi:10.1038/309030a0. PMID 6325925. S2CID 4371931.

web.archive.org

"Cancer Drug Effectiveness Substantially Advanced". Archived from the original on May 7, 2010. Retrieved April 17, 2010.
Couzin-Frankel, Jennifer (8 April 2010). "New Peptide Helps Cancer Drugs Break Into Tumors". ScienceNOW. Archived from the original on June 8, 2013. Retrieved March 14, 2013.

worldcat.org

search.worldcat.org

Ruoslahti, E. (2004). "Vascular zip codes in angiogenesis and metastasis". Biochem Soc Trans. 32 (3): 397–402. doi:10.1042/bst0320397. ISSN 0300-5127. PMID 15157146.